CD8A and cervical squamous cell carcinoma: Exosome-derived miR-142-5p expressed in cervical squamous cell carcinoma inhibits the CD8+ T-cell-mediated immune response via induction of indoleamine-2,3-diogxigenase (IDO) in tumor-associated lymphatic vessels, thereby exhausting the CD8+ cells [94].